Literature DB >> 15162383

Amplification of MMP-2 and MMP-9 production by prostate cancer cell lines via activation of protease-activated receptors.

Susan R Wilson1, Sandra Gallagher, Kate Warpeha, Susan J Hawthorne.   

Abstract

BACKGROUND: The matrix metalloproteinases (MMP) are a family of proteolytic enzymes involved in facilitating cancer metastasis. Protease-activated receptors (PARs) have previously been shown to be involved in pathways of MMP upregulation by tumor cells.
METHODS: Two androgen independent prostate cancer cell lines, PC3 and DU-145, and one androgen dependent prostate cancer line LNCaP, were investigated. PAR expression was detected using RT-PCR and immunofluorochemistry (IFC) techniques. MMP activity assays were used to quantify the levels of MMP-2 and -9 on all three prostate cell lines after PAR activation.
RESULTS: RT-PCR and IFC showed the presence of PAR-1 and PAR-2 in all cell lines investigated, only LNCaP showed PAR-3 and PAR-4 expression. Increased levels of MMP-2 and MMP-9 activity, up to sevenfold depending on prostate cancer cell line, following PAR activation by specific PAR peptides was shown.
CONCLUSION: Preliminary studies show the activation of PAR-1 or PAR-2 produced increased levels of MMP-2 and MMP-9 activity in prostate cancer cell lines, indicating their potential role in the metastasis of prostate cancer cells. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15162383     DOI: 10.1002/pros.20047

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  27 in total

1.  Membrane type-1 matrix metalloproteinase (MT1-MMP) correlates with the expression and activation of matrix metalloproteinase-2 (MMP-2) in inflammatory breast cancer.

Authors:  Diaa Al-Raawi; Helal Abu-El-Zahab; Mohamed El-Shinawi; Mona Mostafa Mohamed
Journal:  Int J Clin Exp Med       Date:  2011-10-11

2.  Porphyromonas gingivalis promotes invasion of oral squamous cell carcinoma through induction of proMMP9 and its activation.

Authors:  Hiroaki Inaba; Hideyuki Sugita; Masae Kuboniwa; Soichi Iwai; Masakazu Hamada; Takeshi Noda; Ichijiro Morisaki; Richard J Lamont; Atsuo Amano
Journal:  Cell Microbiol       Date:  2013-09-19       Impact factor: 3.715

Review 3.  PAR-1 and thrombin: the ties that bind the microenvironment to melanoma metastasis.

Authors:  Maya Zigler; Takafumi Kamiya; Emily C Brantley; Gabriel J Villares; Menashe Bar-Eli
Journal:  Cancer Res       Date:  2011-10-18       Impact factor: 12.701

Review 4.  Proteinase-activated receptors in the lower urinary tract.

Authors:  James D Moffatt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-02-10       Impact factor: 3.000

5.  Proteinase-activated receptor 2 promotes cancer cell migration through RNA methylation-mediated repression of miR-125b.

Authors:  Lan Yang; Yiming Ma; Wenxiao Han; Weiwei Li; Liang Cui; Xinhua Zhao; Yantao Tian; Zhixiang Zhou; Wengong Wang; Hongying Wang
Journal:  J Biol Chem       Date:  2015-09-09       Impact factor: 5.157

6.  Phenotypic analysis of mice lacking the Tmprss2-encoded protease.

Authors:  Tom S Kim; Cynthia Heinlein; Robert C Hackman; Peter S Nelson
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

7.  Tissue inhibitor of metalloproteinases-2 improves antitumor efficacy of a replicating adenovirus in vivo.

Authors:  Myung-hee Kim; Thomas M Bodenstine; Lucretia A Sumerel; Angel A Rivera; Andrew H Baker; Joanne T Douglas
Journal:  Cancer Biol Ther       Date:  2006-12-07       Impact factor: 4.742

8.  The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cells.

Authors:  Susan Wilson; Brett Greer; John Hooper; Andries Zijlstra; Brian Walker; James Quigley; Susan Hawthorne
Journal:  Biochem J       Date:  2005-06-15       Impact factor: 3.857

9.  Lung cancer with gastrointestinal metastasis - review of theories of metastasis with three rare case descriptions.

Authors:  Rohtesh S Mehta; Andrew D Liman; Vida A Passero; Agnes K Liman
Journal:  Cancer Microenviron       Date:  2013-08-21

10.  Novel gene C17orf37 in 17q12 amplicon promotes migration and invasion of prostate cancer cells.

Authors:  S Dasgupta; L M Wasson; N Rauniyar; L Prokai; J Borejdo; J K Vishwanatha
Journal:  Oncogene       Date:  2009-06-08       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.